Schroder Investment Management Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-96,914
| Closed | -$1.97M | – | 1267 |
|
|
2022
Q4 | $1.97M | Sell |
96,914
-12,036
| -11% | -$244K | ﹤0.01% | 945 |
|
|
2022
Q3 | $2.79M | Sell |
108,950
-52,572
| -33% | -$1.35M | ﹤0.01% | 884 |
|
|
2022
Q2 | $4M | Buy |
161,522
+30,588
| +23% | +$757K | 0.01% | 835 |
|
|
2022
Q1 | $3.17M | Sell |
130,934
-7,585
| -5% | -$183K | ﹤0.01% | 936 |
|
|
2021
Q4 | $2.74M | Sell |
138,519
-4,990
| -3% | -$98.8K | ﹤0.01% | 871 |
|
|
2021
Q3 | $2.82M | Sell |
143,509
-12,008
| -8% | -$236K | ﹤0.01% | 909 |
|
|
2021
Q2 | $3.42M | Buy |
155,517
+35,217
| +29% | +$775K | ﹤0.01% | 905 |
|
|
2021
Q1 | $2.86M | Sell |
120,300
-139,622
| -54% | -$3.32M | ﹤0.01% | 941 |
|
|
2020
Q4 | $6.8M | Buy |
259,922
+92,176
| +55% | +$2.41M | 0.01% | 733 |
|
|
2020
Q3 | $2.84M | Sell |
167,746
-9,133
| -5% | -$155K | ﹤0.01% | 834 |
|
|
2020
Q2 | $2.98M | Sell |
176,879
-28,348
| -14% | -$477K | 0.01% | 755 |
|
|
2020
Q1 | $2.37M | Buy |
205,227
+187,365
| +1,049% | +$2.16M | 0.01% | 775 |
|
|
2019
Q4 | $216K | Buy |
17,862
+1,409
| +9% | +$17K | ﹤0.01% | 1155 |
|
|
2019
Q3 | $240K | Buy |
+16,453
| New | +$240K | ﹤0.01% | 1137 |
|
|
2018
Q3 | – | Sell |
-29,680
| Closed | -$469K | – | 1288 |
|
|
2018
Q2 | $469K | Buy |
29,680
+527
| +2% | +$8.33K | ﹤0.01% | 1047 |
|
|
2018
Q1 | $480K | Buy |
29,153
+1,665
| +6% | +$27.4K | ﹤0.01% | 1063 |
|
|
2017
Q4 | $496K | Buy |
27,488
+4,688
| +21% | +$84.6K | ﹤0.01% | 1096 |
|
|
2017
Q3 | $432K | Hold |
22,800
| – | – | ﹤0.01% | 1097 |
|
|
2017
Q2 | $272K | Buy |
+22,800
| New | +$272K | ﹤0.01% | 1131 |
|